At the Charité in Berlin: First Patient in Germany Treated with Gene Scissors
23 Articles
23 Articles
A 19-year-old lives with a genetic disease. Thanks to a drug based on Crispr technology, he should no longer be dependent on blood transfusions.
For the first time outside of a study, the Crispr/Cas9 gene shear is regularly used in Germany. A 19-year-old with a blood disease receives genetically altered stem cells at the Charité - and can now lead a normal life.
Berliner Morgenpost
In Germany, a patient was treated for the first time with a Crispr-based gene therapy. The Charité speaks of a medical breakthrough.
Welt
The developers of the Crispr method received the Nobel Prize in 2020. In Berlin, a patient has now been treated with a drug based on it. How successful was that?
volksfreund.de
The developers of the Crispr method received the Nobel Prize in 2020. In Berlin, a patient has now been treated with a drug based on it. How successful was that?
Berlin – For the first time since the development of CRISPR-Cas9 gene shears, a patient in Germany has been successfully treated outside of studies using the method. The 19-year-old, who suffers from the genetic disease beta-thalassemia, was given a 2024 approved medicine in May of this year in the Berlin Charité, as the...
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
